EPHA2 and breast carcinoma: EphA2 regulates tumor-related neoangiogenesis, which is necessary for tumor maintenances through the PI3K signaling pathway EphA2 protein and mRNA, which are both highly expressed across multiple molecular subtypes of breast cancer (positive rate ~75% and ~84%, respectively) [317].